Work

Structural Basis and Preclinical Efficacy of MG1124, a Novel CEACAM1-Targeting Antibody Synergizing with PD-1 Blockade

Year: 2026

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-26-0454

Authors: Jae-Chul Lee, Miyoung Oh, Hye-mi Nam, Hyun-Jung Cho, Jae Hwan Kim, Byoung Chul Cho, Seonghoon Kim, Byung-Ha Oh, Chang-Woo Lee

Institutions: Sungkyunkwan University, Ewha Womans University, Yonsei University, Gangnam Severance Hospital, Korea Advanced Institute of Science and Technology

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204455547

FWCI:

Cites:

Cited by:

Related to: